Investor Class Action Over AstraZeneca COVID-19 Drug Dismissed With Prejudice

Mealey's (September 15, 2022, 1:29 PM EDT) -- NEW YORK — A federal judge in New York on Sept. 12 ruled that shareholders in a class action against biopharmaceutical company AstraZeneca PLC and certain of its senior officials, who alleged that the defendants misrepresented clinical trial results for the company’s COVID-19 vaccine candidate have failed to plead any actionable misstatements or omissions in violation of federal securities laws....